Elutia Inc. Class A Common Stock (ELUT)

FairStock Score: 53/100 — MIXED

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.14, providing financial flexibility
• Superior net profit margin of 575.9% indicating pricing power and operational efficiency

Concerns

• Revenue declining at 40.2% year-over-year signals potential demand weakness or market share loss
• Altman Z-Score of -2.8 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Elutia Inc. Class A Common Stock is a micro-cap healthcare company valued at $48 million. The business generates $12 million in annual revenue with a 575.9% net margin. From a quality standpoint, Elutia shows distressed Altman Z-Score of -2.8 warrants caution and conservative leverage at 0.14x debt-to-equity. Growth dynamics show revenue growing at -40.2% and profit growth of 881.3%. Our composite FairStock Score of 53/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer